Exploring the crucial structural elements required for tricyclic quinoline analogs as protein kinase CK2 inhibitors by a combined computational analysis
- 10 January 2013
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 22 (9) , 4410-4422
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Structural Determinants of CX-4945 Derivatives as Protein Kinase CK2 Inhibitors: A Computational StudyInternational Journal of Molecular Sciences, 2011
- Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of CancerJournal of Medicinal Chemistry, 2010
- Addiction to protein kinase CK2: A common denominator of diverse cancer cells?Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Docking and 3D-QSAR studies of 7-hydroxycoumarin derivatives as CK2 inhibitorsEuropean Journal of Medicinal Chemistry, 2010
- Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2Biochemical Journal, 2009
- Pharmacophore Identification and Validation Study of CK2 Inhibitors Using CoMFA/CoMSIAChemical Biology & Drug Design, 2009
- Protein kinase CK2 – A key suppressor of apoptosisAdvances in Enzyme Regulation, 2008
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Molecular dynamics with coupling to an external bathThe Journal of Chemical Physics, 1984
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983